NYSE:CL

Colgate-palmolive Company Stock News

Consumer Defensive > Household & Personal Products

Buy CL

*Your capital is at risk

$84.87

-3.40 (-3.85%)

At Close: Jun 03, 2026

3 Champion Stocks That Are Screaming Buys in April

11:57am, Thursday, 07'th Apr 2022 The Motley Fool

Some exciting acquisitions and outstanding quarterly results make these three stocks excellent investments now.

Upcoming Ex-Dividend Dates: April 8-20, 2022

09:30am, Thursday, 07'th Apr 2022

Upcoming Ex-Dividend Dates: April 8-20, 2022

7 Top S&P 500 Stocks to Buy for a Volatile April

06:45am, Thursday, 07'th Apr 2022

Stock market volatility is on the rise. These seven stocks to buy for April can help safeguard your portfolio.

My Dividend Stock Portfolio: March 2022 Update - 101 Holdings And 29 Buys

05:30am, Thursday, 07'th Apr 2022 Seeking Alpha

The war in Ukraine continues to dominate market movements. Read why I am not selling and predominantly focusing on adding dividend income via select purchases.

5 Very Safe Dividend Aristocrats to Buy Now for What Could Be a Very Rocky Q2

07:18am, Monday, 04'th Apr 2022

After the worst quarter for stocks since 2020, many investors have cheered the recent market rally that lifted both the Nasdaq and the Russell 2000 out of bear market territory and being down over 20%

40 Year+ Dividend Builders Boast 5 Buys For April

10:27am, Sunday, 03'rd Apr 2022

40 Year+ Dividend Builders Boast 5 Buys For April

Dividend Champions For April 2022

04:03am, Saturday, 02'nd Apr 2022 Seeking Alpha

Monthly update of the Dividend Champions List. 41 companies declared higher dividends in the past month, with an average increase of 8.48% over their previous payouts.

Expert Ratings For Colgate-Palmolive

08:52pm, Wednesday, 30'th Mar 2022 Benzinga

Analysts have provided the following ratings for Colgate-Palmolive (NYSE:CL) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1 3 0 0 L

4 S&P 500 Aristocrats Are April's Top Dividend Dogs

04:53am, Friday, 25'th Mar 2022

"Dividend Aristocrats. in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing.

Cresco Labs is buying Columbia Care in major cannabis merger that will create biggest U.S. player

11:19am, Thursday, 24'th Mar 2022 MarketWatch

Cresco Labs is paying $2 billion in stock to buy Columbia Care in a deal that will add Virginia and New Jersey to its U.S. footprint as they roll out adult use cannabis.